Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS.

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS (2013) 1.10

A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS One (2013) 0.97

Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale. J Neuroimmune Pharmacol (2013) 0.95

Cognitive Impairment among Persons of Rural Background Living with Human Immunodeficiency Virus Infection on Antiretroviral Therapy: A Study from a Tertiary Care Centre of North India. J Neurosci Rural Pract (2016) 0.75

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology (1991) 5.87

The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology (1993) 3.53

The AIDS dementia complex. J Infect Dis (1988) 2.77

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS (1998) 2.15

Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol (2007) 2.03

Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol (2004) 1.85

Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J Neurovirol (2007) 1.73

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology (1999) 1.71

HIV & psychiatric disorders. Indian J Med Res (2005) 1.54

Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19

Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J Neurovirol (2006) 1.09

Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group. AIDS (1998) 0.93

Neuropsychological evaluation of the HIV patient. Psychiatr Clin North Am (1994) 0.86

Neurocognitive impairment in early HIV-positive individuals. J Indian Med Assoc (2008) 0.84

A clinical and behavioural study of hiv infected subjects-a comparison with std subjects. Indian J Psychiatry (1991) 0.81

A study of psychiatric manifestations of physically asymptomatic hiv - I seropositive individuals. Indian J Psychiatry (2000) 0.81

Rhabdomyolysis in the hyperosmolal state. Am J Med (1990) 2.24

Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J (2000) 1.29

Hypersensitivity angiitis associated with naproxen. Ann Allergy (1989) 0.94

Prevalence and predictors of rhabdomyolysis in patients with hypokalemia. N Engl J Med (1990) 0.87

Abnormal urate transport in patients with intracranial disease. Am J Kidney Dis (1992) 0.84

Hyponatremia and hypouricemia: differentiation from SIADH. Clin Nephrol (1990) 0.81

Plasma natriuretic factor(s) in patients with intracranial disease, renal salt wasting and hyperuricosuria. Life Sci (1993) 0.81

Effect of sertraline hydrochloride on dialysis hypotension. Am J Kidney Dis (1998) 0.78

Hypokalemia and rhabdomyolysis. Miner Electrolyte Metab (1991) 0.76

Validation and usefulness of the Tamil version of the GHQ-12 in the community. Br J Community Nurs (2006) 0.76

Hyperglycemia causing pulmonary edema in patients with end-stage renal disease. Clin Nephrol (1991) 0.75